nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—Dacarbazine—sarcoma	0.21	0.262	CbGbCtD
Sulfadiazine—CYP2E1—Mitoxantrone—sarcoma	0.163	0.203	CbGbCtD
Sulfadiazine—CYP3A4—Thiotepa—sarcoma	0.115	0.143	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—sarcoma	0.103	0.128	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—sarcoma	0.0767	0.0956	CbGbCtD
Sulfadiazine—CYP3A4—Mitoxantrone—sarcoma	0.0494	0.0615	CbGbCtD
Sulfadiazine—CYP3A4—Vincristine—sarcoma	0.034	0.0423	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—sarcoma	0.0311	0.0388	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—sarcoma	0.0212	0.0264	CbGbCtD
Sulfadiazine—Muscle contracture—Dactinomycin—sarcoma	0.0144	0.0728	CcSEcCtD
Sulfadiazine—Necrolysis epidermal—Etoposide—sarcoma	0.00708	0.0359	CcSEcCtD
Sulfadiazine—Skin necrosis—Etoposide—sarcoma	0.0046	0.0233	CcSEcCtD
Sulfadiazine—Eruption—Dactinomycin—sarcoma	0.00361	0.0183	CcSEcCtD
Sulfadiazine—Neuritis—Vincristine—sarcoma	0.00266	0.0135	CcSEcCtD
Sulfadiazine—Anuria—Epirubicin—sarcoma	0.00258	0.0131	CcSEcCtD
Sulfadiazine—Skin necrosis—Epirubicin—sarcoma	0.00258	0.0131	CcSEcCtD
Sulfadiazine—Skin discolouration—Thiotepa—sarcoma	0.00248	0.0126	CcSEcCtD
Sulfadiazine—Oliguria—Thiotepa—sarcoma	0.00243	0.0123	CcSEcCtD
Sulfadiazine—Anuria—Doxorubicin—sarcoma	0.00239	0.0121	CcSEcCtD
Sulfadiazine—Skin necrosis—Doxorubicin—sarcoma	0.00239	0.0121	CcSEcCtD
Sulfadiazine—Skin exfoliation—Thiotepa—sarcoma	0.00214	0.0108	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Dactinomycin—sarcoma	0.00209	0.0106	CcSEcCtD
Sulfadiazine—Sepsis—Thiotepa—sarcoma	0.00194	0.00984	CcSEcCtD
Sulfadiazine—Sepsis—Dactinomycin—sarcoma	0.00193	0.00977	CcSEcCtD
Sulfadiazine—Skin discolouration—Etoposide—sarcoma	0.00178	0.00902	CcSEcCtD
Sulfadiazine—Sepsis—Mitoxantrone—sarcoma	0.00168	0.0085	CcSEcCtD
Sulfadiazine—Polyuria—Vincristine—sarcoma	0.00164	0.00831	CcSEcCtD
Sulfadiazine—Skin exfoliation—Etoposide—sarcoma	0.00154	0.00778	CcSEcCtD
Sulfadiazine—Ataxia—Thiotepa—sarcoma	0.00153	0.00774	CcSEcCtD
Sulfadiazine—Eruption—Epirubicin—sarcoma	0.00147	0.00742	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00145	0.00736	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00145	0.00735	CcSEcCtD
Sulfadiazine—Sepsis—Etoposide—sarcoma	0.0014	0.00707	CcSEcCtD
Sulfadiazine—Eruption—Doxorubicin—sarcoma	0.00136	0.00687	CcSEcCtD
Sulfadiazine—Ataxia—Vincristine—sarcoma	0.00136	0.00686	CcSEcCtD
Sulfadiazine—Burning sensation—Epirubicin—sarcoma	0.0013	0.00657	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00123	0.00624	CcSEcCtD
Sulfadiazine—Stomatitis—Thiotepa—sarcoma	0.00122	0.00618	CcSEcCtD
Sulfadiazine—Stomatitis—Dactinomycin—sarcoma	0.00121	0.00614	CcSEcCtD
Sulfadiazine—Neuritis—Epirubicin—sarcoma	0.00121	0.00612	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Etoposide—sarcoma	0.00121	0.00611	CcSEcCtD
Sulfadiazine—Burning sensation—Doxorubicin—sarcoma	0.0012	0.00608	CcSEcCtD
Sulfadiazine—Agranulocytosis—Thiotepa—sarcoma	0.00117	0.00592	CcSEcCtD
Sulfadiazine—Agranulocytosis—Dactinomycin—sarcoma	0.00116	0.00588	CcSEcCtD
Sulfadiazine—Hallucination—Thiotepa—sarcoma	0.00112	0.00567	CcSEcCtD
Sulfadiazine—Neuritis—Doxorubicin—sarcoma	0.00112	0.00566	CcSEcCtD
Sulfadiazine—Hepatitis—Dactinomycin—sarcoma	0.00112	0.00565	CcSEcCtD
Sulfadiazine—Depression—Vincristine—sarcoma	0.00111	0.00561	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Vincristine—sarcoma	0.00109	0.00551	CcSEcCtD
Sulfadiazine—Stomatitis—Vincristine—sarcoma	0.00108	0.00548	CcSEcCtD
Sulfadiazine—Blood disorder—Epirubicin—sarcoma	0.00108	0.00547	CcSEcCtD
Sulfadiazine—Erythema multiforme—Dactinomycin—sarcoma	0.00106	0.00534	CcSEcCtD
Sulfadiazine—Stomatitis—Mitoxantrone—sarcoma	0.00105	0.00534	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00105	0.00533	CcSEcCtD
Sulfadiazine—Tinnitus—Thiotepa—sarcoma	0.00105	0.00531	CcSEcCtD
Sulfadiazine—Agranulocytosis—Mitoxantrone—sarcoma	0.00101	0.00511	CcSEcCtD
Sulfadiazine—Chills—Thiotepa—sarcoma	0.00101	0.00511	CcSEcCtD
Sulfadiazine—Chills—Dactinomycin—sarcoma	0.001	0.00507	CcSEcCtD
Sulfadiazine—Blood disorder—Doxorubicin—sarcoma	0.000999	0.00506	CcSEcCtD
Sulfadiazine—Skin discolouration—Epirubicin—sarcoma	0.000998	0.00506	CcSEcCtD
Sulfadiazine—Hallucination—Vincristine—sarcoma	0.000992	0.00503	CcSEcCtD
Sulfadiazine—Oliguria—Epirubicin—sarcoma	0.000978	0.00496	CcSEcCtD
Sulfadiazine—Hepatitis—Mitoxantrone—sarcoma	0.000971	0.00492	CcSEcCtD
Sulfadiazine—Skin discolouration—Doxorubicin—sarcoma	0.000923	0.00468	CcSEcCtD
Sulfadiazine—Oliguria—Doxorubicin—sarcoma	0.000905	0.00459	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Etoposide—sarcoma	0.000892	0.00452	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Etoposide—sarcoma	0.000882	0.00447	CcSEcCtD
Sulfadiazine—Stomatitis—Etoposide—sarcoma	0.000877	0.00444	CcSEcCtD
Sulfadiazine—Leukopenia—Thiotepa—sarcoma	0.000876	0.00444	CcSEcCtD
Sulfadiazine—Chills—Mitoxantrone—sarcoma	0.000871	0.00441	CcSEcCtD
Sulfadiazine—Leukopenia—Dactinomycin—sarcoma	0.000869	0.0044	CcSEcCtD
Sulfadiazine—Skin exfoliation—Epirubicin—sarcoma	0.000861	0.00436	CcSEcCtD
Sulfadiazine—Convulsion—Thiotepa—sarcoma	0.000848	0.0043	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Epirubicin—sarcoma	0.000846	0.00429	CcSEcCtD
Sulfadiazine—Agranulocytosis—Etoposide—sarcoma	0.00084	0.00425	CcSEcCtD
Sulfadiazine—Arthralgia—Thiotepa—sarcoma	0.000833	0.00422	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—sarcoma	0.000796	0.00403	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—sarcoma	0.000783	0.00397	CcSEcCtD
Sulfadiazine—Sepsis—Epirubicin—sarcoma	0.000782	0.00396	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Thiotepa—sarcoma	0.000782	0.00396	CcSEcCtD
Sulfadiazine—Vertigo—Vincristine—sarcoma	0.00078	0.00395	CcSEcCtD
Sulfadiazine—Leukopenia—Vincristine—sarcoma	0.000777	0.00394	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Dactinomycin—sarcoma	0.000776	0.00393	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—sarcoma	0.000764	0.00387	CcSEcCtD
Sulfadiazine—Anorexia—Thiotepa—sarcoma	0.000761	0.00386	CcSEcCtD
Sulfadiazine—Leukopenia—Mitoxantrone—sarcoma	0.000757	0.00383	CcSEcCtD
Sulfadiazine—Anorexia—Dactinomycin—sarcoma	0.000756	0.00383	CcSEcCtD
Sulfadiazine—Convulsion—Vincristine—sarcoma	0.000752	0.00381	CcSEcCtD
Sulfadiazine—Convulsion—Mitoxantrone—sarcoma	0.000732	0.00371	CcSEcCtD
Sulfadiazine—Vascular purpura—Epirubicin—sarcoma	0.000732	0.00371	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000728	0.00369	CcSEcCtD
Sulfadiazine—Chills—Etoposide—sarcoma	0.000725	0.00367	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—sarcoma	0.000724	0.00367	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000722	0.00366	CcSEcCtD
Sulfadiazine—Arthralgia—Mitoxantrone—sarcoma	0.00072	0.00365	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Vincristine—sarcoma	0.000708	0.00359	CcSEcCtD
Sulfadiazine—Decreased appetite—Thiotepa—sarcoma	0.000694	0.00352	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Epirubicin—sarcoma	0.000693	0.00351	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Vincristine—sarcoma	0.000693	0.00351	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00069	0.00349	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Thiotepa—sarcoma	0.00069	0.00349	CcSEcCtD
Sulfadiazine—Decreased appetite—Dactinomycin—sarcoma	0.000689	0.00349	CcSEcCtD
Sulfadiazine—Purpura—Epirubicin—sarcoma	0.000679	0.00344	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—sarcoma	0.000677	0.00343	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Epirubicin—sarcoma	0.000676	0.00343	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Mitoxantrone—sarcoma	0.000675	0.00342	CcSEcCtD
Sulfadiazine—Anorexia—Vincristine—sarcoma	0.000675	0.00342	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Epirubicin—sarcoma	0.000671	0.0034	CcSEcCtD
Sulfadiazine—Anorexia—Mitoxantrone—sarcoma	0.000658	0.00333	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Thiotepa—sarcoma	0.000653	0.00331	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Dactinomycin—sarcoma	0.000648	0.00328	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vincristine—sarcoma	0.000645	0.00327	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—sarcoma	0.000642	0.00325	CcSEcCtD
Sulfadiazine—Insomnia—Vincristine—sarcoma	0.000641	0.00325	CcSEcCtD
Sulfadiazine—Urticaria—Thiotepa—sarcoma	0.000635	0.00321	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—sarcoma	0.000632	0.0032	CcSEcCtD
Sulfadiazine—Abdominal pain—Thiotepa—sarcoma	0.000631	0.0032	CcSEcCtD
Sulfadiazine—Body temperature increased—Thiotepa—sarcoma	0.000631	0.0032	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—sarcoma	0.000629	0.00319	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000628	0.00318	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—sarcoma	0.000628	0.00318	CcSEcCtD
Sulfadiazine—Abdominal pain—Dactinomycin—sarcoma	0.000627	0.00317	CcSEcCtD
Sulfadiazine—Body temperature increased—Dactinomycin—sarcoma	0.000627	0.00317	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000626	0.00317	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—sarcoma	0.00062	0.00314	CcSEcCtD
Sulfadiazine—Decreased appetite—Vincristine—sarcoma	0.000616	0.00312	CcSEcCtD
Sulfadiazine—Ataxia—Epirubicin—sarcoma	0.000615	0.00312	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vincristine—sarcoma	0.000611	0.0031	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—sarcoma	0.000609	0.00309	CcSEcCtD
Sulfadiazine—Decreased appetite—Mitoxantrone—sarcoma	0.0006	0.00304	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000589	0.00299	CcSEcCtD
Sulfadiazine—Hypersensitivity—Thiotepa—sarcoma	0.000588	0.00298	CcSEcCtD
Sulfadiazine—Hypersensitivity—Dactinomycin—sarcoma	0.000584	0.00296	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vincristine—sarcoma	0.000579	0.00293	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—sarcoma	0.000574	0.00291	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—sarcoma	0.000569	0.00288	CcSEcCtD
Sulfadiazine—Pruritus—Thiotepa—sarcoma	0.000565	0.00286	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000564	0.00286	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—sarcoma	0.000562	0.00285	CcSEcCtD
Sulfadiazine—Abdominal pain—Vincristine—sarcoma	0.00056	0.00284	CcSEcCtD
Sulfadiazine—Body temperature increased—Vincristine—sarcoma	0.00056	0.00284	CcSEcCtD
Sulfadiazine—Pancreatitis—Epirubicin—sarcoma	0.000555	0.00281	CcSEcCtD
Sulfadiazine—Urticaria—Mitoxantrone—sarcoma	0.000548	0.00278	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—sarcoma	0.000547	0.00277	CcSEcCtD
Sulfadiazine—Diarrhoea—Thiotepa—sarcoma	0.000547	0.00277	CcSEcCtD
Sulfadiazine—Body temperature increased—Mitoxantrone—sarcoma	0.000545	0.00276	CcSEcCtD
Sulfadiazine—Abdominal pain—Mitoxantrone—sarcoma	0.000545	0.00276	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000545	0.00276	CcSEcCtD
Sulfadiazine—Diarrhoea—Dactinomycin—sarcoma	0.000542	0.00275	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vincristine—sarcoma	0.000522	0.00264	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—sarcoma	0.000513	0.0026	CcSEcCtD
Sulfadiazine—Hypersensitivity—Mitoxantrone—sarcoma	0.000508	0.00257	CcSEcCtD
Sulfadiazine—Vomiting—Thiotepa—sarcoma	0.000508	0.00257	CcSEcCtD
Sulfadiazine—Vomiting—Dactinomycin—sarcoma	0.000504	0.00255	CcSEcCtD
Sulfadiazine—Rash—Thiotepa—sarcoma	0.000504	0.00255	CcSEcCtD
Sulfadiazine—Dermatitis—Thiotepa—sarcoma	0.000503	0.00255	CcSEcCtD
Sulfadiazine—Headache—Thiotepa—sarcoma	0.0005	0.00254	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.0005	0.00253	CcSEcCtD
Sulfadiazine—Rash—Dactinomycin—sarcoma	0.0005	0.00253	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—sarcoma	0.000499	0.00253	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—sarcoma	0.000495	0.00251	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Epirubicin—sarcoma	0.000494	0.0025	CcSEcCtD
Sulfadiazine—Stomatitis—Epirubicin—sarcoma	0.000492	0.00249	CcSEcCtD
Sulfadiazine—Diarrhoea—Vincristine—sarcoma	0.000485	0.00246	CcSEcCtD
Sulfadiazine—Nausea—Thiotepa—sarcoma	0.000474	0.0024	CcSEcCtD
Sulfadiazine—Diarrhoea—Mitoxantrone—sarcoma	0.000472	0.00239	CcSEcCtD
Sulfadiazine—Nausea—Dactinomycin—sarcoma	0.000471	0.00239	CcSEcCtD
Sulfadiazine—Agranulocytosis—Epirubicin—sarcoma	0.000471	0.00238	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—sarcoma	0.000469	0.00238	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000463	0.00234	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000457	0.00232	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—sarcoma	0.000456	0.00231	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—sarcoma	0.000455	0.0023	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—sarcoma	0.000454	0.0023	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—sarcoma	0.000454	0.0023	CcSEcCtD
Sulfadiazine—Hepatitis—Epirubicin—sarcoma	0.000453	0.00229	CcSEcCtD
Sulfadiazine—Vomiting—Vincristine—sarcoma	0.00045	0.00228	CcSEcCtD
Sulfadiazine—Rash—Vincristine—sarcoma	0.000447	0.00226	CcSEcCtD
Sulfadiazine—Dermatitis—Vincristine—sarcoma	0.000446	0.00226	CcSEcCtD
Sulfadiazine—Headache—Vincristine—sarcoma	0.000444	0.00225	CcSEcCtD
Sulfadiazine—Vomiting—Mitoxantrone—sarcoma	0.000439	0.00222	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—sarcoma	0.000435	0.00221	CcSEcCtD
Sulfadiazine—Rash—Mitoxantrone—sarcoma	0.000435	0.0022	CcSEcCtD
Sulfadiazine—Dermatitis—Mitoxantrone—sarcoma	0.000435	0.0022	CcSEcCtD
Sulfadiazine—Headache—Mitoxantrone—sarcoma	0.000432	0.00219	CcSEcCtD
Sulfadiazine—Erythema multiforme—Epirubicin—sarcoma	0.000428	0.00217	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—sarcoma	0.000423	0.00214	CcSEcCtD
Sulfadiazine—Tinnitus—Epirubicin—sarcoma	0.000422	0.00214	CcSEcCtD
Sulfadiazine—Nausea—Vincristine—sarcoma	0.000421	0.00213	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—sarcoma	0.000419	0.00212	CcSEcCtD
Sulfadiazine—Nausea—Mitoxantrone—sarcoma	0.00041	0.00208	CcSEcCtD
Sulfadiazine—Chills—Epirubicin—sarcoma	0.000406	0.00206	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—sarcoma	0.000406	0.00206	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—sarcoma	0.000396	0.00201	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—sarcoma	0.000393	0.00199	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—sarcoma	0.000391	0.00198	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—sarcoma	0.000376	0.0019	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—sarcoma	0.000365	0.00185	CcSEcCtD
Sulfadiazine—Rash—Etoposide—sarcoma	0.000362	0.00183	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—sarcoma	0.000361	0.00183	CcSEcCtD
Sulfadiazine—Headache—Etoposide—sarcoma	0.000359	0.00182	CcSEcCtD
Sulfadiazine—Vertigo—Epirubicin—sarcoma	0.000354	0.00179	CcSEcCtD
Sulfadiazine—Leukopenia—Epirubicin—sarcoma	0.000353	0.00179	CcSEcCtD
Sulfadiazine—Convulsion—Epirubicin—sarcoma	0.000341	0.00173	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—sarcoma	0.000341	0.00173	CcSEcCtD
Sulfadiazine—Arthralgia—Epirubicin—sarcoma	0.000336	0.0017	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—sarcoma	0.000328	0.00166	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—sarcoma	0.000326	0.00165	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Epirubicin—sarcoma	0.000322	0.00163	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—sarcoma	0.000316	0.0016	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Epirubicin—sarcoma	0.000315	0.0016	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—sarcoma	0.00031	0.00157	CcSEcCtD
Sulfadiazine—Anorexia—Epirubicin—sarcoma	0.000307	0.00155	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—sarcoma	0.000298	0.00151	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000293	0.00148	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—sarcoma	0.000291	0.00148	CcSEcCtD
Sulfadiazine—Insomnia—Epirubicin—sarcoma	0.000291	0.00147	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—sarcoma	0.000284	0.00144	CcSEcCtD
Sulfadiazine—Decreased appetite—Epirubicin—sarcoma	0.00028	0.00142	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Epirubicin—sarcoma	0.000278	0.00141	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000271	0.00137	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—sarcoma	0.000269	0.00136	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Epirubicin—sarcoma	0.000263	0.00133	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—sarcoma	0.000259	0.00131	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000257	0.0013	CcSEcCtD
Sulfadiazine—Urticaria—Epirubicin—sarcoma	0.000256	0.00129	CcSEcCtD
Sulfadiazine—Abdominal pain—Epirubicin—sarcoma	0.000254	0.00129	CcSEcCtD
Sulfadiazine—Body temperature increased—Epirubicin—sarcoma	0.000254	0.00129	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000243	0.00123	CcSEcCtD
Sulfadiazine—Hypersensitivity—Epirubicin—sarcoma	0.000237	0.0012	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—sarcoma	0.000236	0.0012	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—sarcoma	0.000235	0.00119	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—sarcoma	0.000235	0.00119	CcSEcCtD
Sulfadiazine—Pruritus—Epirubicin—sarcoma	0.000228	0.00115	CcSEcCtD
Sulfadiazine—Diarrhoea—Epirubicin—sarcoma	0.00022	0.00111	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—sarcoma	0.000219	0.00111	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—sarcoma	0.000211	0.00107	CcSEcCtD
Sulfadiazine—Vomiting—Epirubicin—sarcoma	0.000204	0.00104	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—sarcoma	0.000204	0.00103	CcSEcCtD
Sulfadiazine—Rash—Epirubicin—sarcoma	0.000203	0.00103	CcSEcCtD
Sulfadiazine—Dermatitis—Epirubicin—sarcoma	0.000203	0.00103	CcSEcCtD
Sulfadiazine—Headache—Epirubicin—sarcoma	0.000201	0.00102	CcSEcCtD
Sulfadiazine—Nausea—Epirubicin—sarcoma	0.000191	0.000968	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—sarcoma	0.000189	0.000959	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—sarcoma	0.000188	0.000951	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—sarcoma	0.000187	0.00095	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—sarcoma	0.000186	0.000944	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—sarcoma	0.000177	0.000896	CcSEcCtD
